GlassScriptPhysician profile
Natalie M Bee
NPI 1841701760
$62,519.43
in general payments reported to CMS, 2019-2025
24 companies · $7,485 in 2025
The $7,485 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34K · 2022: $7,000 · 2023: $3,706 · 2024: $10K · 2025: $7,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $20K · Food and Beverage: $1,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $20,067.39 |
| Food and Beverage | $1,347.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $29,591.75 | 2021-2025 | Nexplanon |
| Biohaven Pharmaceuticals, INC. | $27,163.26 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $3,269.47 | 2022 | |
| Abbvie INC. | $1,438.66 | 2021-2025 | |
| Novo Nordisk INC | $177.94 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $159.43 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Gilead Sciences, INC. | $89.08 | 2021-2022 | |
| Amarin Pharma, INC. | $84.57 | 2021 | |
| Lucid Diagnostics INC. | $78.32 | 2021-2022 | |
| Lilly USA, LLC | $60.68 | 2022 | |
| Viiv Healthcare Company | $53.13 | 2022-2023 | Apretude |
| Merck Sharp & Dohme LLC | $40.69 | 2022 | |
| Allergan, INC. | $25.83 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $25.05 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.19 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $20.32 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.68 | 2022 | |
| Agile Therapeutics, INC. | $15.10 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.64 | 2021 | |
| Upsher-Smith Laboratories LLC | $12.36 | 2022 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 | |
| Amgen INC. | $11.28 | 2022 | |
| Dynavax Technologies Corporation | $9.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Bee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.